Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-18

Clinical Trial Update: Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation [Phase 3]

View source ↗

Summary

This Phase 3 trial studied discontinuing mycophenolate mofetil (MMF) from a tacrolimus/MMF/steroid regimen after kidney transplantation; the study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
  • PREDNISONE (Prednisone)
  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED